bromodeoxyuridine has been researched along with sb 399885 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barry, C; Foley, AG; Gallagher, HC; Hagan, JJ; Hirst, WD; Hunter, AJ; Regan, CM; Upton, N; Walsh, FS | 1 |
1 other study(ies) available for bromodeoxyuridine and sb 399885
Article | Year |
---|---|
The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats.
Topics: Animals; Antimetabolites; Bromodeoxyuridine; Cell Proliferation; Cytoplasmic Granules; Dentate Gyrus; Dose-Response Relationship, Drug; Entorhinal Cortex; Hippocampus; Immunohistochemistry; Male; Maze Learning; Neural Cell Adhesion Molecules; Neurons; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Sialic Acids; Sulfonamides; Thiophenes | 2008 |